Approval · Notice of Compliance 18403 · 2016
GLUCAGON: Notice of Compliance 18403
Issued August 23, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18403
- Date
- August 23, 2016
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUCAGON | Not yet assigned | — |
Medicinal ingredients
- GLUCAGON (RECOMBINANT DNA ORIGIN) 1 MG per VIAL